Navigation Links
Probiotic Delivery Technology Awarded Third International Patent
Date:12/16/2008

REDMOND, Wash., Dec. 16 /PRNewswire/ -- The Australian Patent Office has issued Nutraceutix, Inc. a patent for BIO-tract. It is the third international patent, from many patents pending, that the technology has been awarded based on BIO-tract's ability to protect sensitive ingredients like probiotic organisms from stomach acid on their way to optimal release sites in the intestinal tract.

Steve Moger, President and CEO of Nutraceutix comments: "Many years ago, we recognized the need for an effective probiotic and nutraceutical delivery technology -- one that draws from proven pharmaceutical principals, but does so in a fashion that is economically feasible in the nutritional supplement marketplace. With BIO-tract, we have addressed this need."

In the case of probiotics, three critical barriers must be overcome to fully benefit the consumer.

    --  Survival of these beneficial, but fragile organisms through the
        manufacturing process
    --  Survival on the store shelf
    --  Safe passage through the harsh stomach acids that may denature the
        organisms

BIO-tract products incorporate proven processes and technologies to overcome these barriers.

How BIO-tract works

Once ingested, BIO-tract tablets form a protective layer, which shields probiotic organisms from the acidic conditions of the stomach. After passing from the stomach to the intestinal tract, the tablets release the organisms at optimal rates determined by formulation.

Broad applications for BIO-tract

Application of the BIO-tract delivery system is not limited to probiotics. It has been applied to many other ingredients that benefit from effective gastric acid protection, buffering, controlled release and once-daily dosing. Custom BIO-tract formulations allow the controlled release of active ingredients at rates ranging from just a few hours to all day long.

Nutraceutix celebrates 25 years of manufacturing excellence

Based in Redmond, Washington, Nutraceutix, Inc. is celebrating its 25th year of manufacturing excellence as a probiotics and nutritional supplements company. Nutraceutix supplies natural probiotic strains and incorporates patented LiveBac(R) shelf-life enhancements and a variety of delivery technologies into custom probiotic products for clients. Nutraceutix also custom formulates and contract manufactures premium controlled-release nutraceuticals that offer enhanced bioavailability, reduced side effects and improved dose compliance. Nutraceutix produces bulk probiotic powders, and manufactures capsules and advanced tablets in bulk or finished bottles in its NSF certified GMP contract manufacturing facility.


'/>"/>
SOURCE Nutraceutix
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Ganeden Biotech Receives Frost & Sullivan Probiotics Product Innovation Award
2. New Young Investigator Grants for Probiotics Research Announced
3. Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research
4. China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company
5. Main Street Gourmet Launches New Probiotic Muffins
6. Isabellas Healthy Bakery Unveils Activate - A New Probiotic Muffin Fortified with GanedenBC30 Probiotic
7. Turtle Island Soup Gets Souped Up with New Probiotic, GandenBC30
8. Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic
9. Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research
10. Ganeden Biotech Obtains Self-Affirmed GRAS Status for Probiotic Ingredient, GanedenBC30 (Bacillus coagulans GBI-30, 6086)
11. China-Biotics, Inc. Launches Shining Probiotics Protein Powder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... 2017 , ... G&L Scientific Inc, a leading provider of ... has announced the opening of new offices in Cambridge, Massachusetts, strengthening and improving ... is the latest step in G&L’s expansion of its global clinical consulting services ...
(Date:1/21/2017)... -- Bioptix, Inc. (Nasdaq: BIOP ... 14, 2017 the Board of Directors of the Company ... certain employees associated with the September 2016 acquisition of ... on January 16, 2017 and terminations are expected to ... severance benefits in certain circumstances of up to one ...
(Date:1/20/2017)... Stock-Callers.com explores the Biotech industry ... most recent performances of select equities. In this morning,s ... ), Abeona Therapeutics Inc. (NASDAQ: ABEO ), ... Sage Therapeutics Inc. (NASDAQ: SAGE ). According ... global Biotech market size is expected to reach $604.40 billion by 2020 due ...
(Date:1/19/2017)... 2017 Research and Markets has announced the ... Cancer Type, Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" ... ... market is projected to reach $15,737 million by 2022 from $6,521 ... 2022. Omic technologies segment accounted for more than ...
Breaking Biology Technology:
(Date:12/15/2016)... 15, 2016 Advancements in biometrics ... wellness and wellbeing (HWW), and security of ... new passenger vehicles begin to feature fingerprint ... heart beat monitoring, brain wave monitoring, stress ... and pulse detection. These will be driven ...
(Date:12/12/2016)... , Dec. 12, 2016  Researchers at ... possibilities for graphene by combining the material with ... highly sensitive pressure detector able to sense pulse, ... a small spider.  The research ... can be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/7/2016)... PUNE, India , December 7, 2016 According to ... NLP, Machine Learning), Software Tool (Facial Expression, Voice Recognition), Service, Application Area, End ... size is estimated to grow from USD 6.72 Billion in 2016 to USD ... Continue Reading ... ...
Breaking Biology News(10 mins):